3D Systems Corp. (DDD)
NYSE:DDD
Want to see DDD full AI Analyst Report?
Top Page
3D Systems
(NYSE:DDD)
Select Model
Select Model
Rating:59Neutral
Price Target:
$3.50
▲(56.25% Upside)
Action:Reiterated
Date:05/14/26
DDD’s score is anchored by improved profitability trends and strong earnings-call operating progress, supported by bullish technicals (price above major moving averages). The main drag is persistently negative operating/free cash flow, with valuation also pressured by a negative P/E and no stated dividend support.
Positive Factors
Revenue & Segment Growth
A return to top-line growth led by Healthcare and Aerospace indicates diversified end markets and rising product adoption. Durable adoption in regulated healthcare and defense increases repeatable revenue, supports installed-base driven consumables and services, and reduces single-market dependency over time.
Negative Factors
Negative Operating & Free Cash Flow
Persistent negative operating and free cash flow undermines the sustainability of reported profit improvements. Until cash generation turns positive, the company may need external financing for capex and working capital, limiting flexibility and increasing execution risk for growth investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Segment Growth
A return to top-line growth led by Healthcare and Aerospace indicates diversified end markets and rising product adoption. Durable adoption in regulated healthcare and defense increases repeatable revenue, supports installed-base driven consumables and services, and reduces single-market dependency over time.
Read all positive factors
3D Systems Key Performance Indicators (KPIs)
Any
Operating Expense Breakdown
Details core costs like R&D, marketing, and admin, offering insight into how efficiently the company runs and where it’s prioritizing investment.
Details core costs like R&D, marketing, and admin, offering insight into how efficiently the company runs and where it’s prioritizing investment.
Data provided by:
The Fly
The Fly3D Systems (DDD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$457.01M
Dividend YieldN/A
Average Volume (3M)3.02M
Price to Earnings (P/E)―
Beta (1Y)1.89
Revenue Growth-10.16%
EPS GrowthN/A
CountryUS
Employees1,833
SectorTechnology
Sector Strength88
IndustryComputer Hardware
Share Statistics
EPS (TTM)0.47
Shares Outstanding146,947,050
10 Day Avg. Volume2,149,285
30 Day Avg. Volume3,021,004
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)0.95
Price to Sales (P/S)0.59
P/FCF Ratio-2.34
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue1.09
Enterprise Value/Gross Profit3.22
Enterprise Value/Ebitda4.55
Forecast
1Y Price Target
$3.70Price Target Upside65.33% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-0.28
Revenue Forecast (FY)$392.57M
3D Systems Business Overview & Revenue Model
Company Description
3D Systems Corporation, through its subsidiaries, provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers 3D printers, such as stereolithography, selective...
How the Company Makes Money
3D Systems makes money primarily by selling additive manufacturing solutions and supporting them over time. Key revenue streams include: (1) Product (printers and systems): Revenue from the sale of 3D printers and related hardware platforms across...
3D Systems Earnings Call Summary
Earnings Call Date:May 11, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 12, 2026
Earnings Call Sentiment Positive
The call conveyed meaningful operational and financial improvement: revenue grew 11% year-over-year, Healthcare grew 21%, Aerospace & Defense grew over 20%, gross margin expanded ~6 points, OpEx fell 35% and adjusted EBITDA turned positive in Q1. Management highlighted successful new product launches (NextDent 300), regulatory approvals, an expanding order backlog and an 80,000 sq ft capacity expansion. Cautions included regional supply-chain/logistics disruptions tied to the Middle East conflict, a temporary key-customer disruption (now resolved), modest FX/tariff headwinds and a conservative Q2 outlook ($93M–$95M revenue; adjusted EBITDA loss $2M–$4M). Overall, the positives — broad-based revenue growth, margin and expense improvements, strong product momentum and clear cost reductions — outweigh the short-term operational headwinds and cautious near-term guidance.Positive Updates
Return to Revenue Growth
Consolidated revenue of $95.5M in Q1, up 11% year-over-year, marking a solid return to top-line growth driven by key markets (Med Tech, Dental, Aerospace & Defense).
Negative Updates
Regional Supply Chain and Logistics Disruptions
Conflict in the Middle East created supply chain and logistics challenges that impacted deliveries and demand in certain regions (notably jewelry business) and created modest negative effects on operations.
Read all updates
Q1-2026 Updates
Positive
Negative
Return to Revenue Growth
Consolidated revenue of $95.5M in Q1, up 11% year-over-year, marking a solid return to top-line growth driven by key markets (Med Tech, Dental, Aerospace & Defense).
Read all positive updates
Company Guidance
Management guided Q2 revenue of $93–95 million with an adjusted EBITDA loss of $2–4 million and reiterated a full‑year objective of breakeven adjusted EBITDA or better. That outlook follows Q1 results of $95.5M revenue (+11% YoY), non‑GAAP gross margin of 36.1% (up ~600 bps YoY), adjusted EBITDA of $2.1M (improvement of $26M YoY, $28.2M adjusted), non‑GAAP operating expense of $36.6M (down 35% YoY), and more than $55M of annualized cost savings delivered; the company finished Q1 with $86.5M total cash ($85.1M cash & equivalents, $1.4M restricted), $3.9M of debt due in Q4 2026 and $92M maturing in 2030. Management said OpEx should remain largely stable for the year, cost‑reduction programs will be complete by end‑Q2, R&D will normalize to a more balanced level, Aerospace & Defense is expected to grow >20% in 2026 (≈$35M), and denture market expansion targets an addressable population of >60 million edentulous patients.3D Systems Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
63
Positive
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 387.90M | 386.90M | 440.12M | 488.07M | 538.03M | 615.64M |
| Gross Profit | 131.61M | 129.78M | 164.18M | 196.42M | 214.23M | 263.78M |
| EBITDA | 93.14M | -65.36M | -214.12M | -325.60M | -81.96M | 356.50M |
| Net Income | 62.45M | 29.88M | -255.59M | -362.69M | -122.71M | 322.05M |
Balance Sheet | ||||||
| Total Assets | 513.12M | 521.73M | 608.85M | 990.66M | 1.45B | 1.55B |
| Cash, Cash Equivalents and Short-Term Investments | 85.08M | 95.64M | 171.32M | 331.52M | 568.74M | 789.66M |
| Total Debt | 57.36M | 158.46M | 286.06M | 399.30M | 500.32M | 502.62M |
| Total Liabilities | 278.77M | 279.18M | 430.69M | 561.90M | 694.91M | 706.72M |
| Stockholders Equity | 234.34M | 240.36M | 176.19M | 426.75M | 749.94M | 842.38M |
Cash Flow | ||||||
| Free Cash Flow | -70.46M | -97.77M | -61.01M | -107.88M | -90.93M | 29.36M |
| Operating Cash Flow | -61.25M | -87.83M | -44.89M | -80.69M | -70.02M | 48.15M |
| Investing Cash Flow | 109.74M | 108.99M | -19.02M | 124.78M | -308.36M | 260.56M |
| Financing Cash Flow | -101.44M | -101.67M | -91.27M | -106.47M | -13.81M | 405.80M |
3D Systems Technical Analysis
Positive
2.24
Price Trends
2.08
Positive
2.11
Positive
2.22
Positive
Market Momentum
-0.01
Negative
62.32
Neutral
93.19
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DDD, the sentiment is Positive. The current price of 2.24 is above the 20-day moving average (MA) of 1.97, above the 50-day MA of 2.08, and above the 200-day MA of 2.22, indicating a bullish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 62.32 is Neutral, neither overbought nor oversold. The STOCH value of 93.19 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DDD.
3D Systems Risk Analysis
3D Systems disclosed 20 risk factors in its most recent earnings report. 3D Systems reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
3D Systems Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $801.62M | 11.60 | 0.87% | ― | 8.03% | ― | |
66 Neutral | $385.16M | -89.85 | 18.31% | ― | -2.54% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $457.01M | -15.22 | 14.09% | ― | -10.16% | ― | |
52 Neutral | $740.22M | -7.08 | -13.44% | ― | -2.96% | 10.37% | |
49 Neutral | $334.86M | -1.27 | -58.73% | ― | 101.52% | -310.43% | |
46 Neutral | $326.89M | -1.29 | -60.72% | ― | 97.15% | 46.65% |
* Technology Sector Average
DDD
3D Systems
3.20
1.45
82.86%
SSYS
Stratasys
8.56
-2.40
-21.90%
NNDM
Nano Dimension
1.65
0.08
5.10%
OSS
One Stop Systems
15.86
13.23
503.04%
CAN
Canaan
0.51
-0.32
-38.92%
CRSR
Corsair Gaming
7.42
-1.32
-15.10%
3D Systems Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
3D Systems Updates Bylaws to Clarify Voting Standards
Neutral
Apr 30, 2026
On April 28, 2026, 3D Systems Corporation’s board adopted amended and restated by-laws that revise Section 2.07 to more closely align the company’s language with Section 216(2) of the Delaware General Corporation Law. The change is des...
Executive/Board Changes
3D Systems Names Phyllis Nordstrom Permanent CFO and CAO
Positive
Mar 26, 2026
On March 23, 2026, 3D Systems appointed Phyllis Nordstrom as Executive Vice President, Chief Financial Officer and Chief Administrative Officer, formalizing the CFO role she had held on an interim basis since August 2025. Her expanded remit keeps ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.